Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?
Journal article published in 2023 by
Lisa Bauer 
,
Debby van Riel
,
Debby van Riel
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Neurological complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are a huge societal problem. Although the neuropathogenicity of SARS-CoV-2 is not yet fully understood, there is evidence that SARS-CoV-2 can invade and infect cells of the central nervous system.